FCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximab.

FCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximab.

Item
http://www.wikidata.org/entity/Q33712230
Evaluation of antibody-dependent cell-mediated cytotoxicity activity and cetuximab response in KRAS wild-type metastatic colorectal cancer patients.Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer.Prognostic and predictive biomarkers in metastatic colorectal cancer anti-EGFR therapy.FCGR2A, FCGR3A polymorphisms and therapeutic efficacy of anti-EGFR monoclonal antibody in metastatic colorectal cancer.Genotypes Affecting the Pharmacokinetics of Anticancer Drugs.The KRAS-Variant and Cetuximab Response in Head and Neck Squamous Cell Cancer: A Secondary Analysis of a Randomized Clinical Trial.FcγR requirements leading to successful immunotherapy.Germline polymorphisms as biomarkers of tumor response in colorectal cancer patients treated with anti-EGFR monoclonal antibodies: a systematic review and meta-analysis.Associations between single-nucleotide polymorphisms and inflammatory bowel disease-associated colorectal cancers in inflammatory bowel disease patients: a meta-analysis.
P2860

FCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximab.

Item
http://www.wikidata.org/entity/Q33712230
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
FCGR2A and FCGR3A polymorphism ...... and oxaliplatin +/- cetuximab.
@ast
FCGR2A and FCGR3A polymorphism ...... and oxaliplatin +/- cetuximab.
@en
type
label
FCGR2A and FCGR3A polymorphism ...... and oxaliplatin +/- cetuximab.
@ast
FCGR2A and FCGR3A polymorphism ...... and oxaliplatin +/- cetuximab.
@en
prefLabel
FCGR2A and FCGR3A polymorphism ...... and oxaliplatin +/- cetuximab.
@ast
FCGR2A and FCGR3A polymorphism ...... and oxaliplatin +/- cetuximab.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P478
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
FCGR2A and FCGR3A polymorphism ...... and oxaliplatin +/- cetuximab.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P478
P577
P5875
P6179
P698
P921
P932